Public
All

ST PHARM's Public Release

ST PHARM NewsST PHARM, Participated in TIDES USA 2022 Conference As a Gold sponsorMay 2, 2022
Media FocusKorean drugmakers team up with CEPI to become global vaccine suppliersDec 27, 2021
Media FocusST Pharm receives presidential award for improving labor-management relationsDec 1, 2021
Media FocusKorea-based ST Pharm takes leap towards world's largest oligonucleotide CDMONov 30, 2021
ST PHARM NewsST PHARM to Expand Oligonucleotide FacilityNov 29, 2021
ST PHARM NewsST PHARM Announces Expansion of Oligonucleotide Facility, Taking a Leap Towards the World's Largest Oligonucleotide CDMONov 29, 2021
Media FocusKorean companies eyeing mRNA vaccines to treat cancerAug 17, 2021
ST PHARM NewsST PHARM Announces Publication of Preclinical Data for HIV-1 / AIIDS Treatment Drug 'STP0404'Jul 22, 2021
Media FocusKorea launches mRNA vaccine consortiumJun 29, 2021
ST PHARM NewsST PHARM, The First Company Developing mRNA-LNP Vaccine in South KoreaJun 1, 2021
Media FocusST Pharm begins developing Korea's 1st LNP-based mRNA Covid-19 vaccineJun 1, 2021
Media FocusKorean companies work on RNA Covid-19 treatments, vaccinesApr 15, 2021
Media FocusFDA Approves Zolgensma, first gene therapy for SMAJun 11, 2019
4of5
HOMEPublicPR (Public Relations)News roomAll
© 2024 ST Pharm. All rights reserved.